The following is a summary of “Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension,” ...

Purpose: The clinical benefits, adverse effects, pharmacokinetics, and recommendations for the appropriate use of the aldosterone antagonists spironolactone and eplerenone in patients with heart ...

The aldosterone-renin ratio (ARR) has gained popularity as a screening test for primary hyperaldosteronism, a probably underdiagnosed cause of hypertension. However, studies have yielded varying ...

A new blood pressure medication called lorundrostat has shown promising results in reducing blood pressure among patients ...

Radnor, Pennsylvania-based Mineralys is a clinical-stage biopharmaceutical company developing treatments for hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA), and other ...

Aldosterone antagonists (spironolactone, eplerenone) also known as “potassium sparing diuretics” block the action of aldosterone inhibiting the reuptake of sodium and water. Normally ...

The study is evaluating the efficacy and safety of lorundrostat, a novel aldosterone synthase inhibitor, in treating ...

By using two different drugs, researchers are targeting the renin-angiotensin-aldosterone system, a hormone system that regulates blood pressure and fluid balance in the body. If the renin-angiotensin ...

You’ve viewed 1 of 5 articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.